Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GILD | BMY | VRTX | ||
| Company | Gilead Sciences Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 90.92 | 56.22 | 395.72 | ||
| High | 93.29 | 57.33 | 401.31 | ||
| Low | 90.71 | 56.08 | 386.49 | ||
| Last | 92.57 | 57.33 | 397.27 | ||
| Change | +1.48 | +1.03 | +0.63 | ||
| % Change | +1.62% | +1.83% | +0.16% | ||
| Volume | 22,530,100 | 48,212,000 | 6,203,100 | ||
| 20-Day Average Volume | 7,592,390 | 11,813,050 | 1,820,960 | ||
| Previous Close | 91.09 | 56.30 | 396.64 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 91.97 | 57.98 | 456.96 | ||
| 20-Day Raw Stochastic | 62.18% | 40.60% | 19.69% | ||
| 20-Day Relative Strength | 55.07% | 52.59% | 29.29% | ||
| Weighted Alpha | +25.30 | +17.93 | -11.23 | ||
| Today's Opinion | 100% Buy | 80% Buy | 72% Sell | ||
| Previous Opinion | 88% Buy | 80% Buy | 56% Sell | ||
| Last Month's Opinion | 80% Buy | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.78% since 12/13/24 | +2.78% since 12/13/24 | -14.33% since 12/13/24 | ||
| Low | 90.27 on 12/19/24 | 55.68 on 12/16/24 | 377.85 on 12/19/24 | ||
| High | 93.59 on 12/17/24 | 58.54 on 12/18/24 | 474.18 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | +4.45% since 11/20/24 | -0.95% since 11/20/24 | -11.96% since 11/20/24 | ||
| Low | 88.07 on 11/21/24 | 55.04 on 12/13/24 | 377.85 on 12/19/24 | ||
| High | 94.65 on 12/11/24 | 60.68 on 11/25/24 | 476.46 on 12/10/24 | ||
| 3-Month | |||||
| %Chg | +10.28% since 09/20/24 | +16.03% since 09/20/24 | -14.55% since 09/20/24 | ||
| Low | 81.83 on 09/26/24 | 49.11 on 09/25/24 | 377.85 on 12/19/24 | ||
| High | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | +35.16% since 06/20/24 | +39.69% since 06/20/24 | -15.72% since 06/20/24 | ||
| Low | 66.01 on 07/05/24 | 39.35 on 07/05/24 | 377.85 on 12/19/24 | ||
| High | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 115,366,840 | 116,275,392 | 102,308,544 | ||
| Shares Outstanding, K | 1,246,266 | 2,028,177 | 257,529 | ||
| Annual Sales | 27,116,000,000 | 45,006,000,000 | 9,869,200,000 | ||
| Annual Net Income | 5,665,000,000 | 8,025,000,000 | 3,619,600,000 | ||
| Last Quarter Sales | 7,545,000,000 | 11,892,000,000 | 2,771,900,000 | ||
| Last Quarter Net Income | 1,253,000,000 | 1,211,000,000 | 1,045,400,000 | ||
| 60-Month Beta | 0.18 | 0.45 | 0.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.02 on 11/06/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | ||
| Latest Earnings Date | 02/11/25 | 02/06/25 | 02/03/25 | ||
| Most Recent Dividend | 0.770 on 12/13/24 | 0.600 on 10/04/24 | N/A | ||
| Next Ex-Dividends Date | 12/13/24 | 01/03/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 20.56 | 48.12 | 0.00 | ||